Amarendra Pegu
National Institutes of Health(US)Intarcia Therapeutics (United States)(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
HIV Research and Treatment, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment
Most-Cited Works
- → Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates(2020)1,152 cited
- → Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants(2021)591 cited
- → Enhanced neonatal Fc receptor function improves protection against primate SHIV infection(2014)393 cited
- → Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants(2021)356 cited
- → A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges(2016)306 cited
- → Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo(2014)285 cited